KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy. (Q53304753)

13 May 2018

title

KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy. (English)

1 reference

13 May 2018

0 references

9

1 reference

13 May 2018

Klaus Jung

3

object named as

Klaus Jung

1 reference

13 May 2018

author name string

Jochen Gaedcke

1

1 reference

13 May 2018

Marian Grade

2

1 reference

13 May 2018

Markus Schirmer

4

1 reference

13 May 2018

Peter Jo

5

1 reference

13 May 2018

Christoph Obermeyer

6

1 reference

13 May 2018

Hendrik A Wolff

7

1 reference

13 May 2018

Markus K Herrmann

8

1 reference

13 May 2018

Heinz Becker

10

1 reference

13 May 2018

Thomas Ried

11

1 reference

13 May 2018

Michael Ghadimi

12

1 reference

13 May 2018

publication date

11 November 2009

1 reference

13 May 2018

Radiotherapy and Oncology

published in

1 reference

13 May 2018

volume

94

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

76-81

1 reference

13 May 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

cites work

1 reference

12 December 2020

Individual tumorigenesis pathways of sporadic colorectal adenocarcinomas are associated with the biological behavior of tumors

1 reference

12 December 2020

Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab

1 reference

12 December 2020

Recurrence and survival after total mesorectal excision for rectal cancer

1 reference

12 December 2020

Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins

1 reference

12 December 2020

K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.

1 reference

12 December 2020

Ras oncogenes: split personalities

1 reference

12 December 2020

Mutations of the BRAF gene in human cancer

1 reference

12 December 2020

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

12 December 2020

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

12 December 2020

Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice

1 reference

12 December 2020

Recurrent KRAS codon 146 mutations in human colorectal cancer

1 reference

12 December 2020

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

1 reference

12 December 2020

Molecular genetic changes associated with colorectal carcinogenesis are not prognostic for tumor regression following preoperative chemoradiation of rectal carcinoma.

1 reference

12 December 2020

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

12 December 2020

Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas

1 reference

12 December 2020

The Ras radiation resistance pathway.

1 reference

12 December 2020

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

1 reference

12 December 2020

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

1 reference

12 December 2020

BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair

1 reference

12 December 2020

Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.

1 reference

12 December 2020

Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer

1 reference

12 December 2020

Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.

1 reference

12 December 2020

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 reference

12 December 2020

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype

1 reference

12 December 2020

RAF/RAS oncogenes and mismatch-repair status

1 reference

12 December 2020

Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context.

1 reference

12 December 2020

Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer: comparison between sonographic and histopathologic changes

1 reference

12 December 2020

Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer

1 reference

12 December 2020

1 reference

12 December 2020

Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy

1 reference

12 December 2020

Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas.

1 reference

12 December 2020

Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.

1 reference

12 December 2020

Integration of novel agents into combined-modality treatment for rectal cancer patients

1 reference

12 December 2020

Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors

1 reference

12 December 2020

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

1 reference

12 December 2020

10.1016/J.RADONC.2009.10.001

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018